Drug-Peptide Conjugates Change Structure and Membrane Interactions for TB Drug Delivery | Research

The takeaway

Conjugating the TB drug isoniazid to cell-penetrating peptides altered their structure and membrane interactions, with different CPPs showing similar cell entry but markedly different subcellular localization and anti-TB activity.

Same entry, different destination
Penetratin and Transportan INH conjugates entered cells equally but had markedly different subcellular localization and anti-Mtb activity

What the researchers found

INH-CPP conjugates showed conjugation-induced structural and membrane interaction changes that correlated with each other; Penetratin and Transportan conjugates had similar cell uptake but different subcellular localization and anti-Mtb activity.

Why it matters

TB kills over a million people annually. CPP-delivered drugs that reach the right intracellular compartments could improve treatment of this hard-to-reach pathogen.

The numbers in context

Multiple CPPs tested; Penetratin and Transportan conjugates had similar uptake but different localization and anti-Mtb activity

How the study worked

In-vitro study using Langmuir balance membrane interaction assays, circular dichroism spectroscopy, AFM imaging, and cellular uptake/anti-Mtb activity assays with INH-CPP conjugates.

Who was studied

EBC-1 human squamous cell carcinoma cells with intracellular M. tuberculosis

What this study cannot tell us

In-vitro study with one cancer cell line; limited Mtb strains tested; conjugation may affect INH drug activity independently of delivery; in-vivo pharmacokinetics not assessed.

How to read the evidence

Comprehensive biophysical characterization with complementary techniques, but preliminary biological evaluation limited to one cell line and in-vitro conditions.

When this study was published

Published in 2020; CPP-based TB drug delivery remains an active research area addressing intracellular pathogen treatment.

The bigger picture

This study reveals that for intracellular drug delivery, getting inside the cell is not enough — the CPP must also deliver cargo to the right subcellular compartment where the pathogen resides.

Questions still open

Which CPP delivers INH specifically to the phagosome where Mtb resides?
Could CPP selection be optimized based on subcellular targeting to improve TB treatment?
How do INH-CPP conjugates perform against drug-resistant TB strains?

Common questions

Can peptides help deliver TB drugs inside cells?

Cell-penetrating peptides can carry TB drugs into cells where the bacteria hide, but this study shows the peptide must deliver the drug to the right compartment inside the cell to be effective.

Why is TB hard to treat?

TB bacteria hide inside human immune cells in specific compartments. Drugs must not only enter cells but reach these compartments to kill the bacteria — a challenge that CPP delivery aims to solve.

Read the original research

Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides.

International journal of molecular sciences, 21(6)

View on PubMed ↗Publisher’s paper ↗

Citation

Pári, Edit; Horváti, Kata; Bősze, Szilvia; Biri-Kovács, Beáta; Szeder, Bálint; Zsila, Ferenc; Kiss, Éva. (2020). Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides.. International journal of molecular sciences, 21(6). https://doi.org/10.3390/ijms21062197